Cardiomyopathy and HF Flashcards

1
Q

clinical features of HD syndrome

A
  1. dyspnea
  2. fatigue
  3. signs of circulatory congestion
  4. hypoperfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

systolic HF more common among

A

middle-aged men (associated with CAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

diastolic HF usually seen in

A

elderly women (HTN, obesity and Diabetes after menopause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most common discharge dx with more dollars and medicare spent on dx and tx than any other disease

A

Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

principle pathophysiological feature of HF

A

inability of heart to fill or empty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HF syndrome may result from these 5 things

A
  1. impaired contractility
  2. valve abnormalities
  3. systemic HTN
  4. pericardial disease
  5. pulmonary HTN (cor pulmonale)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what BBB and which type of HF in combination has a high risk for sudden death

A

LBBB + systolic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hallmark of chronic LV systolic dysfunction

A

DEC EF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

symptomatic patients with normal/near normal LV systolic function (EF > 40%) most likely due to ___ ___

A

diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DHF prevalence for these ages:
<45
50-70
>70

A

<45 — <15%
50-70 — 35%
>70 —- > 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

in diastolic dysfunction, hypertrophied LV is prone to ischemia; therefore maintenance of a ___ (low/high) MAP and ___ (low/high) normal HR is crucial.

A

high MAP

slow normal HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DHF: factors that predispose to poor LV distensibility

A
  1. myocardial edema
  2. fibrosis
  3. hypertrophy
  4. aging
  5. pressure overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

most common causes of DHF:

A
  1. ischemic HD
  2. long-standing HTN
  3. progressive Ao stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DHF more common in which sex

A

women > men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

characteristic heart sound or gallop rhythm present in SHF and DHF

A

SHF – 3rd heart sound

DHF – 4th heart sound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most common cause of left side HF

A

Right side HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

most prominent signs in right HF

A

peripheral edema

congestive hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

this type of output failure have may normal CI at rest but inadequate for stress

A

low-output failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

type of output failure from INC hemodynamic burden

A

high-output failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

most common causes of low-output failure

A
CAD
cardiomyopathy
HTN
valvular dis
pericardial dis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

most common causes of high-output failure

A
anemia
pregnancy
a-v fistulas
severe hyperthyroidism
beriberi
Paget's
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HF: adaptive mechanisms to maintain CO

A
  1. INC SV (frank starling)
  2. SNS activation
  3. alt INOTROPY, HR, afterload
  4. humorally mediated response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

key change in progression of HF

A

remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

according frank starling, SV is directly related to

A

LVEDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

HF compensatory mechanisms: how does SNS activation affect CO

A

(RAAS) inc venous tone - shift blood from peripheral to central = VR enhanced = CO maintained via frank starling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what activates RAAS (kidney related)

A

DEC in renal blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what does RAAS activation do in renal tubuls

A

reabsorption of Na and H2O
inc blood volume = inc CO by FS relationship
good for short-term but contributes to deterioration long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

HF: in SNS activation what is happening to beta-adrenergic receptors and CAT. Ultimately this causes ____.

A
  • down-regulation of beta-adrenergic receptors
  • inc CATS (urine and plasma)
  • high NE levels (directly cardiotoxic)
  • leads to remodeling
  • what Beta-Blockers aim at reducing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Systolic HF + LOW CO = SV is ___

any INC in CO depends on what?

A

SV is fixed
INC HR
(SHF + low EF) tachycardia is expected finding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

goal of HR in DHF

A

prevent tachycardia (inadequate filling time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

humorally mediated response: generalized vasoconstriction initiated by 5 things:

A
  1. SNS activity and RAAS
  2. PSNS withdrawal
  3. High vasopressin levels
  4. endothelial dysfunction
  5. inflammatory mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

function of BNP production in HF

A

promotes BP

protects form effects of volume/pressure overload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

physiologic effects of BNP in HF:

A
(VANDI)
vasodilation
anti-inflammatory
natriuresis
diuresis
inhibitinon of RAAS and SNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

both ANP and BNP inhibit what
(even thou blunted over time)
can give exogenous in acute HF

A

hypertrophy
fibrosis
remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

most common cause of myocardial remodeling

A

ischemic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

1st line tx in HF

A
ACE inh
aldosterone inh
(promote reverse-remodeling)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

earliest subjective finding of HF

A

dyspnea

-starts with exertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

why orthopnea in HF

A

inability of failing LF to handle increased VR when supine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Hallmark Sx of LOW cardiac reserve and CO

A

fatigue and weakness at rest

or with minimal exertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

“classic” findings of LV failure

A

tachypnea
moist rales
- mild HF - bases
- pulm edema - diffuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what is S3 sound known as and what causes (physiological)

A
  • ventricular gallop

- blood entering and distending a noncompliant LV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

sign of severe chronic HF
-due to high metabolic rate, anorexia, nausea, dec intestinal absorption, dec splanchnic venous congestion, HIGH CYTOKINES (interferon and interleukins)

A

cardiac cachexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

BPN levels and indications

can be affected by gender, adv age, renal, obesity, PE, dysrhythmia

A

<100 negative
100-500 probable HF
> 500 consistent with HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

2 drug classes favorable influence on long term outcomes

A

ACE inh

Beta Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

benefits of ACE inh

A

promote vasodilation
reduce water and sodium reabsorption
supports potassium conservation
dec ventricular remodeling (potentiates reversal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

side effects of ACE inh

A

BP, syncope, renal dysfx, HYPERkalemia,

non productive cough, angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

similar but NOT superior to ACE inh
given ONLY to those who cant tolerate ACE inh
benefit to those with returning angiotensis increase

A

ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

aldosterone does what

also potassium levels

A

sodium and H2O retention
hypokalemia
remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

monitor what levels with aldosterone antagonist (which are incorpoprated as 1st line therapy in all HF)

A

renal fx

potassium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

excessive doses of diuretics may lead to 3 things

A

hypovolemia
prerenal azotemia (high cr, bun, waste)
undesirable LOW CO w/ worst clinical outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

digoxin improves survival (t/f)

A

F

this is uncertain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

digoxin caution in

A

elderly

impaired renal

53
Q

dig toxicity Sx:

tx:

A

Sx: anorexia, nausea, blurred vision and dysrhythmias

Tx: reverse HYPOkalemia, antidigoxin antibodies, TPM (pacer)

54
Q
vasodilators' action on:
LV ejection:
venous capacitance
ventricular filling pressures
SV
A

DEC resistance to LV ejection
INC venous capacitance
DEC ventricular filling presures
INC SV

55
Q

benefit of statins in HF

A

anti-inflammatory and lipid lowering

DEC morbidity and mortality in SH

56
Q

BEST treatment for DHF

A

prevention

  • most tx is empirical/experimental
  • no drug selectively diastolic fx
57
Q

what caution to use with diuretics in DHF

A

want to relieve pulm congestion w/o significantly reducing preload (bc u want to optimize ventricular filling)

58
Q

what physiologically causes cough in ACE inh (NH 202)

A

breakdown of bradykinin

-this does not occur in ARBs

59
Q

CRT (cardiac reshynch therapy): where are leads introduced?

A

ventricular leads introduced via coronary sinus into epicardial coronary vein
-advanced to LATERAL WALL of LV

60
Q

CRT (cardiac resynch therapy) recommended for:

A

NYHA Class III or IV
EF < 35%
QRS > 120 - 150 ms

61
Q

caveat to CRT to keep in mind

A

therapy fails to improve 2/3 of patients that receive therapy!

62
Q

ICD indication in HF from CAD

A

EF < 35%

EF < 40% w/ EP study demonstrating inducable ventricular dysrhythmias

63
Q

ICD indications in all other causes of HF (excluding CAD)

A

after first episode of syncope or aborted ventricular tachycardia/v-fib

64
Q

major differences btw 1st and 2nd generation LVADs

A

2nd Gen (NONpulsatile)
quieter
smaller
less thromboebolic risks

65
Q

LVAD: percutaneous lead purpose and anesthetic implications.

A

“drive line”
exists right side of abdomen
connects pump to external console and power
– where exits skin (RUQ) site most likely to be infected
– do not let prep w/ iodine/providone (plastic breakdown) – drape out of field instead

66
Q

most common LVAD in US

A

HeartMate II (2nd gen continuous flow)

67
Q

LVAD: General anesthetic implications

A
periop anticoagulation mngmt
cardiac rhythm devices
antibiotic prophylaxis
connection to power source
AVOIDANCE of chest compression (dislodges cannula)
USE BIPOLAR catery instead of MONO (or direct current away)
NIBP - no pulse
Pulse ox - no pulse
USE cerebral oximeter 
may need US for a-line placement
68
Q

percutaneous VAD designed for cardiac support up to how many days to bridging to CABG/stenting or stabilization

A

14

69
Q

2 types of PVAD

A

Impalla

Tandemheart

70
Q

absolute CI to impella (PVAD)

A

prosthetic valve
severe aortic stenosis
aortic regurge
peripheral vascular disease

71
Q

complications of impella (PVAD) due to centrifugal force

A

hemolysis

thrombocytopenia (ie tearing of RBC’s)

72
Q

complications of TandemHeart (PVAD)

A

paradoxical emboli
right - left shunt (seen in hypoxemia)
coronary sinus/RA injury
** cannula dislodgement and MV entrapment is the worse complication**

73
Q
Preop mngmt of these in HF:
diuretics:
ACEinh:
ARBs:
digoxin:
A
  • diuretics: may D/C day of surgery
  • ACEinh: continue only if treating HTN (not remodeling)
  • ARBs: D/C day BEFORE surgery
  • digoxin: CONTINUE until day of sugery
74
Q

described as the most important risk factor for perioperative morbidity and mortality

A

HF

75
Q

how can PPV and PEEP be benefitial intraop in HF

A

decrease pulm congestion

improve arterial oxygenation

76
Q

cardiomyopathy groups: (primary or secondary)

  • confined to heart muscle
  • genetic, acquired, or mixed
A

primary

77
Q

cardiomyopathy groups: (primary or secondary)

-pathophysiological involvement of heart that is involved in multiorgan disorder

A

secondary

78
Q

cardiomyopathy pathological cause: intrinsic or extrinsic

- DEC contractility of heart muscle that cannot be attributed to specif outside source

A

intrinsic

79
Q

cardiomyopathy pathological cause: intrinsic or extrinsic
-directly attributed to disease process or toxin that adversely damages cardiac muscle (ischemia, chronic inflammation, congenital HD, metabolic, toxins

A

extrinsic

80
Q

4 major forms of cardiomyopathy

A

1 dilated
2 hypertrophic
3 secondary restrictive
4 arrhythmogenic RV

81
Q

cardiomyopathy groups: genetic list

A

*hypertrophic (most common genetic 1/500 incidence)
*arrhythmogenic RV
LV noncompaction
glycogen storage dis
conduction dis (Lenegre’s)
Ion channel issues (brugada, QT)

82
Q

cardiomyopathy groups: mixed list

A

dilated cardiomyopathy*

primary restrictive nonhypertrophic

83
Q

cardiomyopathy groups: acquired list*

A
  • myocarditis (viral, bacterial, rickettsial, fungal, parasitic (chagas’s)
  • stress cardiomyopathy
  • peripartum cardmpthy
84
Q

cardiomyopathy groups: infiltrative

A

amyloidosis*
gaucher’s dis
hunter’s syn

85
Q

cardiomyopathy groups: storage

A

hemochromatosis *
glycogen storage dis
niemann-pick dis

86
Q

cardiomyopathy groups: toxic*

A
  • drugs (cocaine, alcohol
  • chemo (doxorubicin, daunorubicin, cyclophospohamide)
  • heavy metals (lead, murcury)
  • radiation therapy
87
Q

cardiomyopathy groups: inflammatory

A

sarcoidosis*

88
Q

cardiomyopathy groups: endomyocardial

A

hypereosinophilic (loffler’s syn)

endomyocaridal fibrosis

89
Q

cardiomyopathy groups: endocrine

A

DM
hyperthyroidism or hypo
pheo
acromegaly

90
Q

cardiomyopathy groups: neuromuscular

A

Duchenne-Becker dystrophy
neurofibromatosis
tuberous sclerosis

91
Q

cardiomyopathy groups: autoimmune

A
lupus
RA
scleroderma
dermatomyositis
polyarteritis nodosa
92
Q

most common genetic CV disease

characterized by LVH with no disease (ie HTN, aortic stenosis)

A

Hypertophic CM

93
Q

in hypertophic CM, what structures are commonly form hypertrohpy

A

septum

anterolateral free wall

94
Q

Hypertophic CM: LVOT is bound anteiorly by ___ and posteriorly by ____ leaflet of MV

A
IV septum (anterior)
anterior leaflet of MV (posterior)
95
Q

Hypertophic CM: systolic contractiono of hypertophied septum accelerates blood flow thru LVOT creating ___ effect on anteior leaflet of MV (pulls it into LVOT!) –> accentuation LVOT obstruction –> Significant MR

A

Venturi effect

96
Q

hypertrophic CM: LV relies on LA for volume and contraction around __ % of total volume. Keep in NSR

A

75

97
Q

events that INC outflow obstruction:

A

Inc HR, Dec BP and volume

  • increased contractility
  • decresased preload (hypovelemia, vasodilators, tachy, PPV)
  • decreased afterload (hypotension, vasodilators)
98
Q

events that DEC outflow obstruction

A
  • DEC contractility (volatiles, CCB, BB)
  • INC preload (hypervolemia, brady)
  • INC afterload (HTN, a-adrenergic stimulation)
99
Q

hypertrophic CM: physical exam findings (not symptoms)

A

double apical pulse
gallop rhythm
murmur and thrill

100
Q

hypertrophic CM: risk of sudden death more likely in this age group

A

10 - 30 yo

101
Q

hypertrophic CM: ECG

A

LVH
high QRS voltage
ST/T changes
Qs resembling MI

102
Q

hypertrophic CM: echo findings

A

EF > 80% and LVOT obstruction

103
Q

hypertrophic CM: cardiac cath findings

A

pressure gradients

decrease in LV cavity

104
Q

hypertrophic CM: definitive dx

A

endomyocardial biopsy

DNA analysis

105
Q

hypertrophic CM: treatment main goal is to minimize LVOT obstruction.. what about goal for diastolic filling?

A

prolong diastole with:
BB
CCB - improve v-filling

106
Q

hypertrophic CM: these hemodynamics will worse LVOT

A

SNS
hypovolemia
vasodilation

107
Q

Per NH, this cardiomyopathy is the most common cause of sudden death in peds and young adult population

A

hypertrophic CM

108
Q
NH: HCM anesthetic considerations regarding: 
preload: 
HR: 
afterload: 
depth of anesthesia:
myocardial depression
A
  • ensure adequate preload (NH says increase)
  • HR: AVOID tachycardia
  • afterload: increase
  • ensure adequate depth of anesthesia (dont want SNS response!)
  • myocardial depression IS desirable
109
Q

NH: how does increasing contractility worsen HCM?

A

BASICALLY - GREATER LVOT OBSTRUCTION

  • exacerbates the outflow obsruction by increasing septal wall contraction and decreasing CO.
  • increased BF velocity causes greater degree of systolic anterior motion of MV’s anterior leaflet, causing more obstruction
110
Q

HCM: which NMB to avoid

A

pancuronium (tachycardia)

those that release histamine

111
Q

HCM: contraindicated vasoactives

A

dopamine
dobutamine
ephedrine

112
Q

HCM: why avoid vasodilators

A

can inc LVOT obstruction (by decreasing afterload)

113
Q

most common form of CM
3rd most common cause of HF
most common indication for transplant
most common in adult, men (esp. black)

A

dilated CM

114
Q

in HCM: PCWP goal

A

maintain 19-25

bc of DEC diastolic compliance, PCWP DOES NOT equal LVEDV

115
Q

DCM: medication treatment

A

diuretics
ACEIs
digoxin
anticoags

116
Q

RCM: causes

A

genetic (familial CM)
infiltrative (SARCOIDOSIS)
storage dis ( HEMOCHROMATOSIS)
endomyocardial dysfunction (FIBROSIS)

117
Q

RCM: genetic explanation

A

INC sensitivity of troponin and tropomysin complex though to be involved

118
Q

RCM: rarest prevalence in ___

A

children

119
Q

A RVDCM: S and Sx manifest in adolescence

A
tachy
ventricular dysrhythmiaa
T-wave inversion (V1-3)
BBB
hypokinetic RV
DEC RV ejection
JVD
syncope
peripheral edema
120
Q

A RVDCM: common dysrhythmia

A

PVC all way to AFIB

very sensitive to CATs - potentiates lethal rhythms

121
Q

A RVDCM: which antiarhythmic best

A

amio

122
Q

Cor pulmonale: causes

A

COPD - MOST COMMON
restrictive lung ds
respiratory insuff of central origin (OHS - obesity hypoventilation syn)

123
Q

Cor Pulmonale: epidemiology

A

> 50 yo

men 5x > women

124
Q

Cor Pulmonale: main characteristic

A

PulmHTN

125
Q

Cor Pulmonale: 3 signs of severe PHTN

A

accentuation of pulm component of S2
diastolic murmur dt incompetent pulm valve
systolic murmur dt TR

126
Q

Cor Pulmonale: ECG signs

A

peaked P waves (lead I, II, III, avF)
RAD, RBBB
normal EKG does not exclude PHTN

127
Q

Cor Pulmonale: med tx

A

diuretics
digitalis
pulm vasodilators (sildenafil - viagra)

128
Q

Cor Pulmonale: DEC SVR in patients w/ FIXED PHTN can cause

A

SEVERE hypotension!